Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | TYMP | P19971 | 3/20 | 0.38 |
| ▸ | HPRT1 | P00492 | 5/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20691935 | 0.78 | P2RX3 (0.42) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL21539864 | 0.70 | ALDH1A1 (0.63) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL20691971 | 0.68 | ADCY5 (0.35) | TYMPADORA3 | |
| SCHEMBL9308280 | 0.67 | ALDH1A1 (0.60) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL21263957 | 0.67 | ALDH1A1 (0.41) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL2842311 | 0.67 | TYMP (0.39) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL5438533 | 0.67 | ALDH1A1 (0.58) | ALDH1A1LMNAALBMAPK1HPRT1 | |
| SCHEMBL10394462 | 0.66 | ALDH1A1 (0.59) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL21540015 | 0.65 | ALDH1A1 (0.73) | ALDH1A1LMNAALBMAPK1TYMP | |
| SCHEMBL20671325 | 0.65 | ADORA3 (0.53) | ALDH1A1LMNAALBMAPK1TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752516-B1 | CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2022-02-23 | — | — | EP | disclosed |